Catatonia is a risk factor for neuroleptic malignant syndrome

J Clin Psychiatry. 2004 Dec;65(12):1722-3. doi: 10.4088/jcp.v65n1219d.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use
  • Catatonia / diagnosis
  • Catatonia / epidemiology*
  • Comorbidity
  • Humans
  • Neuroleptic Malignant Syndrome / classification
  • Neuroleptic Malignant Syndrome / diagnosis
  • Neuroleptic Malignant Syndrome / epidemiology*
  • Psychiatric Status Rating Scales
  • Risk Factors

Substances

  • Antipsychotic Agents